The Hailey-Hailey family of chronic benign familial thromboembolism is a dubious disease in the field of autoimmune and rheumatic immunity, with complex clinical outcomes and often involving multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory tests, and pathological biopsies.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of chronic benign familial thrombosis Hailey-Hailey require individualized development, typically including multidimensional management of drug therapy, rehabilitation interventions, regular follow-up, etc. In recent years, with the development of therapeutic-focused, immune-regulatory therapy, and precision medicine, many previously difficult-to-treat autoimmune and rheumatoid immune disorders have been significantly improved.
Treatment requires close monitoring of therapeutic efficacy and adverse reactions, with timely regulation according to changing conditions. Multidisciplinary collaboration MDT is particularly important for the comprehensive management of chronic benign familial thrombosis Hailey-Hailey. The platform serves the China International Medical Service System, which combines a team of authoritative experts at home and abroad in the field of autoimmunity and rheumatic immunity, to provide the following services to patients: 1.
Remote pre-diagnosis: Pre-examination of medical records, clear diagnostic directions and medical advice by the team of experts; 2. Interviews in China: Arrangement with authoritative experts for face-to-face diagnosis, development of personalized treatment plans; 3. Full-service: One-stop services: medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: Establishment of a chronic disease management file, continuous monitoring of disease changes and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.












